ArticleBlood2022

SOD2 V16A amplifies vascular dysfunction in sickle cell patients by curtailing mitochondria complex IV activity.

Atinuke Dosunmu-Ogunbi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.